Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

SNPs Outside Response Elements Impact Aryl Hydrocarbon Receptor (AHR) Binding and Gene Regulation: Genome‐wide SNP‐dependent Transcriptional Regulation
Wang, Liewei , Weinshilboum, Richard M. , Neavin, Drew , Liu, Duan , Li, Hu , Weinshilboum, Richard M.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.694.3 Get It

BACKGROUND Most functionally‐significant single nucleotide polymorphisms (SNPs) are outside of open reading frames. Mechanisms by which these SNPs contribute to gene regulation are poorly understood. Aryl hydrocarbon receptor (AHR) is a nuclear receptor that regulates drug metabolism, xenobiotic response and immune response. Our previous data indicate that SNPs outside response elements can impact transcription factor binding and gene regulation. We hypothesized that SNPs near but outside AHR response elements (AhREs) might impact AHR binding and gene regulation. METHODS We have collected dense SNP‐genotypes across 300 lymphoblastoid cell lines (LCLs) – a powerful tool for generating and testing pharmacogenomic hypotheses. Eight LCLs were used to generate hypotheses about AHR SNP‐dependent transcription utilizing RNA‐ and ChIP‐seq, which were tested in additional LCLs using qRT‐PCR and ChIP after AHR agonist or antagonist treatment. RESULTS 69 genes were highly significantly differentially expressed after agonist or antagonist treatment and 80% of those genes had an AhRE within 50kb. Five SNP‐gene pairs have been functionally validated in additional LCLs (Table 1). CONCLUSION SNPs that are outside of AhREs can alter AHR binding and gene transcription. This is a general phenomenon that may have large‐scale influence on gene transcriptional regulation and pharmacogenomics. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication
Wang, Dejie , Ma, Jian , Botuyan, Maria Victoria , Yan, Yuqian , Ding, Donglin , Zhou, Yingke , Krueger, Eugene W. , Jiang, Pei , Wu, Xiaosheng , Wang, Liguo , Pei, Huadong , McNiven, Mark A. , Ye, Dingwei , Mer, Georges , Cui, Gaofeng , Zhou, Yingke , Krueger, Eugene W , Pei, Jiang , Wang, Liguo , Ye, Dingwei , Mer, Georges , Huang, Rui , Ye, Dingwei , Huang, Haojie

Mayo Clinic

Science Advances | June 18, 2021 | Volume: 7 | Issue: 25 | Pages: No page available

10.1126/sciadv.abd9208 | PMID 34144977 Get It

SPOP mutation disables 53BP1 ubiquitination and exclusion from DNA double-strand break sites and causes genome instability.
Mild to moderate COVID-19 illness in adult outpatients
Blair, Janis E. , Gotimukul, Ashwini, Mina, Syeda A. , Bartels, Helen Caroline , Burns, Mark W. , Kole, Amy E., Vikram, Holenarasipur R. , Gea‐Banacloche, Juan , Seville, Maria Teresa , Petty, Skye A. Buckner, Vikram, Avinash, Orenstein, Robert , Wang, Fangfang, Bartels, Helen C, Vikram, Holenarasipur R. , Wang, Fangfang, Burns, Mark W., Kole, Amy

Mayo Clinic

Medicine | June 17, 2021 | Volume: 100 | Issue: 24 | Pages: e26371

10.1097/md.0000000000026371 | PMID 34128896 Get It

Abstract Most patients with coronavirus disease 2019 (COVID-19) have mild to moderate illness not requiring hospitalization. However, no study has detailed the evolution of symptoms in the first month of illness. At our institution, we conducted remote (telephone and video) visits for all adult outpatients diagnosed with COVID-19 within 24 h of a positive nasopharyngeal polymerase chain test for SARS-CoV-2. We repeated regular video visits at 7, 14, and 28 days after the positive test, retrospectively reviewed the prospective data collected in the remote visits, and constructed a week by week profile of clinical illness, through week 4 of illness. We reviewed the courses of 458 symptomatic patients diagnosed between March 12, 2020, and June 22, 2020, and characterized their weekly courses. Common initial symptoms included fever, headache, cough, and chest pain, which frequently persisted through week 3 or longer. Upper respiratory or gastrointestinal symptoms were much shorter lived, present primarily in week 1. Anosmia/ageusia peaked in weeks 2 to 3. Emergency department visits were frequent, with 128 visits in the 423 patients who were not hospitalized and 48 visits among the 35 outpatients (7.6%) who were eventually hospitalized (2 subsequently died). By the fourth week, 28.9% said their illness had completely resolved. After the 4-week follow up, 20 (4.7%) of the 423 nonhospitalized patients had further medical evaluation and management for subacute or chronic COVID-19 symptoms. Mild to moderate outpatient COVID-19 is a prolonged illness, with evolving symptoms commonly lasting into the fourth week of illness.
IMPACT OF TIME TO RELAPSE AND RESPONSE TO SALVAGE THERAPY ON POST AUTOLOGOUS STEM CELL TRANSPLANT OUTCOMES IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Wang, Y, Maliske, Seth , Micallef, Ivana N. , Inwards, David J. , Porrata, Luis F. , Ansell, Stephen M. , Kharfan‐Dabaja, Mohamed A. , Nowakowski, Grzegorz S. , Johnston, Patrick B. , Tun, Aung M. , Farooq, Umar , Rosenthal, Allison , Link, Brian K. , Villasboas, José C. , Paludo, Jonas , Cerhan, James R. , Habermann, Thomas M. , Witzig, Thomas E.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.98_2880 Get It

INTERIM PET/CT PREDICTS OUTCOMES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH FRONTLINE LENALIDOMIDE/RCHOP (R2CHOP): LONG‐TERM ANALYSIS OF MC078E
LaPlant, Betsy, Macon, William R. , King, Rebecca L. , Wang, Y., Inwards, David J. , Micallef, Ivana N. , Johnston, Patrick B. , Porrata, Luis F. , Ansell, Steven M., Nowakowski, G. S., Desai, Sanjal H. , Young, J., Habermann, Thomas M. , Witzig, Thomas E.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.83_2880 Get It

DO CELL‐OF‐ORIGIN, DOUBLE EXPRESSER, AND DOUBLE HIT STATUS AFFECT OUTCOMES IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (R/R DLBCL)? A PROSPECTIVE OBSERVATIONAL STUDY
Mwangi, Raphael , King, Rebecca L. , Feldman, Andew L., Thompson, C., Wang, Y., Ansell, Steven M., Nowakowski, GS, Desai, Sanjal H. , Maurer, Matthew J. , Cerhan, James R. , Habermann, Thomas M. , Farooq, Umar , Witzig, Thomas E.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.66_2879 Get It

THREE PHASE 1/2, OPEN‐LABEL STUDIES OF CEREBLON E3 LIGASE MODULATOR (CELMOD)‐BASED REGIMENS IN NEWLY DIAGNOSED (ND) OR RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)
Nowakowski, G. S., Kesanakurthy, V., Gkasiamis, Argyrios, Patah, Poliana, Delarue, Richard, Wang, T., Xian, Dehai , Martin, Peter , Morschhauser, Franck , Cartron, Guillaume , Li, J., Xian, D., Fox, Christopher P.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.173_2880 Get It

PROGRESSION‐FREE SURVIVAL AT 24 MONTHS AS A LANDMARK AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Maliske, Seth , Wang, Y, Micallef, Ivana N. , Inwards, David J. , Porrata, Luis F. , Kharfan‐Dabaja, Mohamed A. , Orme, Jacob J. , Thompson, Carrie A. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Johnston, Patrick B. , Tun, Aung M. , Maurer, Matthew J. , Rosenthal, Allison , Link, Brian K. , Cerhan, James R. , Habermann, Thomas M. , Witzig, Thomas E. , Farooq, Umar

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.97_2880 Get It

CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)
Herrera, Alex F. , Ansell, Stephen M. , Maddocks, Kami J. , Negievich, Yanina, Cruz, Hans G. , Wang, L., Wuerthner, Jens, Zinzani, Pier Luigi , Carlo‐Stella, Carmelo , Hamadani, Mehdi , Radford, John , Kline, Justin Paul , Savage, Kerry J. , Bartlett, Nancy L. , Caimi, Paolo F. , Collins, Graham P.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.75_2879 Get It